Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Evotec SE    EVT   DE0005664809

EVOTEC SE

(EVT)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/29/2019 | 11:00am EDT

DGAP Total Voting Rights Announcement: Evotec SE / Total Voting Rights Announcement
Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

29.03.2019 / 16:56
Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of total number of voting rights

1. Details of issuer
Evotec SE
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany

2. Type of capital measure
  Type of capital measure Date of status / date of effect
X Conditional capital increase (Sec. 41 para. 2 WpHG) 29.03.2019
  Other capital measure (Sec. 41 para. 1 WpHG)

3. New total number of voting rights:
149765064



29.03.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Evotec SE
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany
Internet: www.evotec.com

 
End of News DGAP News Service

793627  29.03.2019 

fncls.ssp?fn=show_t_gif&application_id=793627&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EVOTEC SE
07/15EVOTEC : Expands its ipsc discovery platform
EQ
07/12EVOTEC SE : Notification and public disclosure of transactions by persons
EQ
07/08Eurofins to slow pace of M&A, expand in emerging markets
RE
07/08EVOTEC : and venture capital consortium form 'Breakpoint Therapeutics GmbH'
AQ
07/08EVOTEC : And venture capital consortium form 'breakpoint therapeutics gmbh'
EQ
07/04EVOTEC : completes acquisition of Just Biotherapeutics
AQ
07/03EVOTEC SE : Notification and public disclosure of transactions by persons
EQ
07/03EVOTEC : Completes acquisition of just biotherapeutics
EQ
06/28EVOTEC SE : Release according to Article 41 of the WpHG [the German Securities T..
EQ
06/27EVOTEC : places first Schuldschein worth EUR 250 m
AQ
More news
Financials (EUR)
Sales 2019 417 M
EBIT 2019 76,6 M
Net income 2019 55,3 M
Finance 2019 64,1 M
Yield 2019 -
P/E ratio 2019 64,7x
P/E ratio 2020 65,0x
EV / Sales2019 9,09x
EV / Sales2020 8,16x
Capitalization 3 852 M
Chart EVOTEC SE
Duration : Period :
Evotec SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVOTEC SE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 26,2  €
Last Close Price 25,8  €
Spread / Highest target 27,9%
Spread / Average Target 1,51%
Spread / Lowest Target -22,5%
EPS Revisions
Managers
NameTitle
Werner Lanthaler Chief Executive Officer
Wolfgang Plischke Chairman-Supervisory Board
Craig L. Johnstone Chief Operating Officer & Member-Management Board
Enno Spillner Chief Financial Officer
Cord E. Dohrmann Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC SE48.34%4 217
IQVIA HOLDINGS INC36.35%31 409
LONZA GROUP30.00%25 111
CELLTRION, INC.--.--%20 827
INCYTE CORPORATION27.99%17 419
EXACT SCIENCES CORPORATION84.14%15 001